Studying the effect of the silencing and the pharmaceutical inhibition of the histone demethylase KDM6B in MYCN-amplified NB cells, D’Oto et al. found a relevant reduction in cell viability and proliferation, most likely due to the downregulation of MYCN and E2F transcriptional signatures [14]. This evidence concerns the gene MYCN and neuroblastoma.